{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:26:15Z","timestamp":1770740775382,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,15]],"date-time":"2015-01-15T00:00:00Z","timestamp":1421280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.clinthera.2014.12.017","type":"journal-article","created":{"date-parts":[[2015,2,26]],"date-time":"2015-02-26T01:49:29Z","timestamp":1424915369000},"page":"816-829.e10","source":"Crossref","is-referenced-by-count":21,"title":["The Impact of 2-Dose Routine Measles, Mumps, Rubella, and Varicella Vaccination in France on the Epidemiology of Varicella and Zoster Using a Dynamic Model With an Empirical Contact Matrix"],"prefix":"10.1016","volume":"37","author":[{"given":"Mario J.N.M.","family":"Ouwens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kavi J.","family":"Littlewood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Sauboin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bertrand","family":"T\u00e9hard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Denis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Yves","family":"Bo\u00eblle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Alain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2014.12.017_bib1","series-title":"Vaccines","article-title":"Varicella vaccine","author":"Gershon","year":"2004"},{"key":"10.1016\/j.clinthera.2014.12.017_bib2","first-page":"265","article-title":"Varicella and herpes zoster vaccines. WHO position paper","volume":"89","year":"2014","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.clinthera.2014.12.017_bib3","unstructured":"Bilan Annuel 2010 du Reseau Sentinelle. http:\/\/websenti.u707.jussieu.fr\/sentiweb\/?rub=39. Accessed March 4, 2014."},{"key":"10.1016\/j.clinthera.2014.12.017_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.inf.0000195636.43584.bb","article-title":"Seroprevalence of varicella in the French population","volume":"25","author":"Khoshnood","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.clinthera.2014.12.017_bib5","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1017\/S0950268802007720","article-title":"Varicella in non-immune persons: incidence, hospitalization and mortality rates","volume":"129","author":"Bo\u00eblle","year":"2002","journal-title":"Epidemiol Infect"},{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2014.12.017_bib6","first-page":"182","article-title":"Varicella in France: national survey of complications and hospitalisations","volume":"24","author":"Grimprel","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.clinthera.2014.12.017_bib7","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0140-6736(06)69561-5","article-title":"Varicella","volume":"368","author":"Heininger","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2014.12.017_bib8","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.revmed.2006.12.004","article-title":"Immunization of adults against varicella and herpes zoster [in French]","volume":"28","author":"Hanslik","year":"2007","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.clinthera.2014.12.017_bib9","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1086\/320884","article-title":"Characteristics of patients with herpes zoster on presentation to practitioners in France","volume":"33","author":"Chidiac","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2014.12.017_bib10","first-page":"497","article-title":"Herpes zoster: incidence study among \u201csentinel\u201d general practitioners","volume":"128","author":"Czernichow","year":"2001","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.clinthera.2014.12.017_bib11","doi-asserted-by":"crossref","first-page":"8326","DOI":"10.1016\/j.vaccine.2007.09.066","article-title":"Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"25","author":"Pellissier","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.clinthera.2014.12.017_bib12","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0304-3959(96)03122-3","article-title":"Pain and its persistence in herpes zoster","volume":"67","author":"Dworkin","year":"1996","journal-title":"Pain"},{"key":"10.1016\/j.clinthera.2014.12.017_bib13","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1017\/S0950268800004714","article-title":"Modelling the impact of immunization on the epidemiology of varicella zoster virus","volume":"125","author":"Brisson","year":"2000","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.clinthera.2014.12.017_bib14","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1097\/INF.0b013e31825d33f9","article-title":"Herpes Zoster in a partially vaccinated pediatric population in central Israel","volume":"31","author":"Stein","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.clinthera.2014.12.017_bib15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2807\/esm.10.01.00511-en","article-title":"Varicella zoster virus vaccination policies and surveillance strategies in Europe","volume":"10","author":"Pinot de Moira","year":"2005","journal-title":"Euro Surveill"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2014.12.017_bib16","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1002\/jmv.10313","article-title":"Epidemiology of varicella-zoster virus in England and Wales","volume":"70","author":"Brisson","year":"2003","journal-title":"J Med Virol"},{"key":"10.1016\/j.clinthera.2014.12.017_bib17","first-page":"9","article-title":"The Nature of Herpes Zoster: A Long-term Study and a New Hypothesis","volume":"58","author":"Hope-Simpson","year":"1965","journal-title":"Proc R Soc Med"},{"key":"10.1016\/j.clinthera.2014.12.017_bib18","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0140-6736(02)09837-9","article-title":"Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study","volume":"360","author":"Thomas","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2014.12.017_bib19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1473-3099(03)00857-0","article-title":"What does epidemiology tell us about risk factors for herpes zoster?","volume":"4","author":"Thomas","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.clinthera.2014.12.017_bib20","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1017\/S0950268800050019","article-title":"The epidemiology of varicella-zoster virus infections: the influence of varicella on the prevalence of herpes zoster","volume":"108","author":"Garnett","year":"1992","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.clinthera.2014.12.017_bib21","first-page":"185","article-title":"Varicella vaccination: a double-edged sword?","volume":"5","author":"Edmunds","year":"2002","journal-title":"Commun Dis Public Health"},{"key":"10.1016\/j.clinthera.2014.12.017_bib22","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.medmal.2009.04.009","article-title":"Impact of routine pediatric varicella vaccination on the epidemiology of herpes zoster [in French]","volume":"39","author":"Alain","year":"2009","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.clinthera.2014.12.017_bib23","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1016\/j.vaccine.2010.02.079","article-title":"Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zoster","volume":"28","author":"Brisson","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.clinthera.2014.12.017_bib24","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1006\/bulm.1999.0126","article-title":"Modeling the Effects of Varicella Vaccinations Programs on the Incidence of Chickenpox and Shingles","volume":"61","author":"Schuette","year":"1999","journal-title":"Bull Math Biol"},{"key":"10.1016\/j.clinthera.2014.12.017_bib25","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0140-6736(12)61461-5","article-title":"Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trial","volume":"383","author":"Prymula","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2014.12.017_bib26","unstructured":"Bilan Annuel 2006 du Reseau Sentinelle. http:\/\/websenti.u707.jussieu.fr\/sentiweb\/?rub=39. Accessed March 4, 2014."},{"key":"10.1016\/j.clinthera.2014.12.017_bib27","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1371\/journal.pmed.0050074","article-title":"Social Contacts and Mixing Patterns Relevant to the Spread of Infectious Diseases","volume":"5","author":"Mossong","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.clinthera.2014.12.017_bib28","unstructured":"Plan d\u2019\u00e9limination de la rougeole et de la rub\u00e9ole cong\u00e9nitale en France. http:\/\/www.sante.gouv.fr\/IMG\/pdf\/plan_elimination_rougeole.pdf. Accessed 17 December, 2013."},{"key":"10.1016\/j.clinthera.2014.12.017_bib29","unstructured":"Silverman B, Hemo B, Friedman N. Varicella vaccine effectiveness in an Israeli health maintenance organisation. Abstract presented at: 27th Annual Meeting of the European Society for Paediatric Infectious Diseases; June 9\u201313, 2009; Brussels, Belgium."},{"key":"10.1016\/j.clinthera.2014.12.017_bib30","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.respe.2008.07.087","article-title":"Modelling the impact of vaccination on the epidemiology of varicella zoster virus [in French]","volume":"56","author":"Bonmarin","year":"2008","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1016\/j.clinthera.2014.12.017_bib31","unstructured":"Estimation de la population au 1er janvier par r\u00e9gion, d\u00e9partement (1975-2014), sexe et \u00e2ge (quinquennal, classes d'\u00e2ge). http:\/\/www.insee.fr\/fr\/themes\/detail.asp?ref_id=estim-pop&reg_id=99 Accessed in January 20, 2015."},{"key":"10.1016\/j.clinthera.2014.12.017_bib32","unstructured":"Littlewood K, Ouwens M, Sauboin C, et al. Cost-effectiveness of routine MMRV vaccination in France: An economic analysis based on a dynamic transmission model for varicella and herpes zoster. Clin Ther"},{"key":"10.1016\/j.clinthera.2014.12.017_bib33","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1017\/S0950268809990768","article-title":"Modelling the impact of varicella vaccination on varicella and zoster","volume":"138","author":"Karhunen","year":"2010","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.clinthera.2014.12.017_bib34","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1017\/S0950268809990860","article-title":"Modelling the impact of one-dose vs. two-dose vaccination regimens on the epidemiology of varicella zoster virus in Australia","volume":"138","author":"Gao","year":"2010","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.clinthera.2014.12.017_bib35","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/cid\/ciq077","article-title":"Herpes zoster incidence among insured persons in the United States, 1993\u20132006: Evaluation of impact of varicella vaccination","volume":"52","author":"Leung","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2014.12.017_bib36","doi-asserted-by":"crossref","first-page":"e1002673","DOI":"10.1371\/journal.pcbi.1002673","article-title":"Inferring the structure of social contacts from demographic data in the analysis of infectious diseases spread","volume":"8","author":"Fumanelli","year":"2012","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.clinthera.2014.12.017_bib37","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.vaccine.2011.01.037","article-title":"Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England","volume":"29","author":"Van Hoek","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.clinthera.2014.12.017_bib38","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.mbs.2008.12.009","article-title":"Using empirical social contact data to model person to person infectious disease transmission: an illustration for varicella","volume":"218","author":"Ogunjimi","year":"2009","journal-title":"Math Biosci"},{"key":"10.1016\/j.clinthera.2014.12.017_bib39","doi-asserted-by":"crossref","first-page":"e60732","DOI":"10.1371\/journal.pone.0060732","article-title":"Perspectives on the Impact of Varicella Immunization on Herpes Zoster. A Model-Based Evaluation from Three European Countries","volume":"8","author":"Poletti","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.clinthera.2014.12.017_bib40","doi-asserted-by":"crossref","first-page":"739","DOI":"10.7326\/0003-4819-159-11-201312030-00006","article-title":"Examination of links between herpes zoster incidence and childhood varicella vaccination","volume":"159","author":"Hales","year":"2013","journal-title":"Ann Intern Med"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291814008789?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291814008789?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T08:18:55Z","timestamp":1566375535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291814008789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0149291814008789"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2014.12.017","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]}}}